If you are not happy with the results below please do another search
Biogen will take a $650 million stake in Sage Therapeutics and make an upfront payment of $875 million to jointly develop and sell treatments for depression and other neurological disorders.
Ten Covid-19 vaccines could be available by the middle of 2021 if they win regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said.
A review of recently published scientific studies includes a detailed imaging analysis to determine how SARS-CoV-2, the virus that causes Covid-19, reprograms infected cells.
Despite the constant need for social distancing, mask-wearing and the isolation and economic uncertainty that resulted from the Covid-19 outbreak, there is still much to be thankful for when families gather around a virtual table to break bread and carve the turkey this year.
AstraZeneca is likely to run an additional global trial to assess the efficacy of the company’s Covid-19 vaccine using a lower dosage, the British drugmaker’s chief executive was quoted as saying amid questions over the results of a late-stage study.
Americans defied pleas from state and local officials to stay home for the Thanksgiving holiday in the face of the surging coronavirus pandemic, triggering fresh warnings from health officials with the release of vaccines still weeks away.
After capturing record-breaking attendance at its spring Illuminate event, the Healthcare Businesswomen’s Association (HBA) brought together – virtually – the biggest Annual Conference crowd in the group’s history with more than 1,600 attendees from 15 countries representing 250 healthcare and life science companies.
A study showed the use of convalescent plasma provided no clinical benefit nor improved mortality in Covid-19 patients with pneumonia.
The global tally of confirmed coronavirus cases hit 60 million on Nov. 25, with the pace of new infections accelerating and the United States reporting record numbers of hospitalizations, according to a Reuters tally.
Kate Cronin, Global CEO of Ogilvy Health, shares her views on a variety of healthcare industry topics in a Q&A with Med Ad News.